1
|
Chiorazzi N: Cell proliferation and death:
Forgotten features of chronic lymphocytic leukemia B cells. Best
Pract Res Clin Haematol. 20:399–413. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Günther C, Martini E, Wittkopf N, Amann K,
Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath
MF, et al: Caspase-8 regulates TNF-α-induced epithelial necroptosis
and terminal ileitis. Nature. 477:335–339. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jäättelä M: Multiple cell death pathways
as regulators of tumour initiation and progression. Oncogene.
23:2746–2756. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Nikoletopoulou V, Markaki M, Palikaras K
and Tavernarakis N: Crosstalk between apoptosis, necrosis and
autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Teng X, Degterev A, Jagtap P, Xing X, Choi
S, Denu R, Yuan J and Cuny GD: Structure-activity relationship
study of novel necroptosis inhibitors. Bioorg Med Chem Lett.
15:5039–5044. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Linkermann A: Beyond necroptosis -
regulated necrosis in the kidney. Cancer Res. 74((Suppl 19)):
SY29–04. 2014.
|
8
|
Linkermann A and Green DR: Necroptosis. N
Engl J Med. 370:455–465. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Su L, Quade B, Wang H, Sun L, Wang X and
Rizo J: A plug release mechanism for membrane permeation by MLKL.
Structure. 22:1489–1500. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Vanden Berghe T, Linkermann A,
Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis:
The expanding network of non-apoptotic cell death pathways. Nat Rev
Mol Cell Biol. 15:135–147. 2014. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Vandenabeele P, Galluzzi L, Vanden Berghe
T and Kroemer G: Molecular mechanisms of necroptosis: An ordered
cellular explosion. Nat Rev Mol Cell Biol. 11:700–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang H, Sun L, Su L, Rizo J, Liu L, Wang
LF, Wang FS and Wang X: Mixed lineage kinase domain-like protein
MLKL causes necrotic membrane disruption upon phosphorylation by
RIP3. Mol Cell. 54:133–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhou W and Yuan J: Necroptosis in health
and diseases. Semin Cell Dev Biol. 35:14–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Panossian A and Wikman G: Pharmacology of
Schisandra chinensis Bail. An overview of Russian research and uses
in medicine. J Ethnopharmacol. 118:183–212. 2008.
|
15
|
Chun JN, Cho M, So I and Jeon JH: The
protective effects of Schisandra chinensis fruit extract and its
lignans against cardiovascular disease: A review of the molecular
mechanisms. Fitoterapia. 97:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Batchelor J and Miyabe K: Ainu economic
plants. Transactions of the Asiatic Society of Japan. R. Meiklejohn
Co. 51:198–240. 1893.
|
17
|
Park JY, Lee SJ, Yun MR, Seo KW, Bae SS,
Park JW, Lee YJ, Shin WJ, Choi YW and Kim CD: Gomisin A from
Schisandra chinensis induces endothelium-dependent and direct
relaxation in rat thoracic aorta. Planta Med. 73:1537–1542. 2007.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Chen P, Pang S, Yang N, Meng H, Liu J,
Zhou N, Zhang M, Xu Z, Gao W, Chen B, et al: Beneficial effects of
schisandrin B on the cardiac function in mice model of myocardial
infarction. PLoS One. 8:e794182013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Min HY, Park EJ, Hong JY, Kang YJ, Kim SJ,
Chung HJ, Woo ER, Hung TM, Youn UJ, Kim YS, et al:
Antiproliferative effects of dibenzocyclooctadiene lignans isolated
from Schisandra chinensis in human cancer cells. Bioorg Med Chem
Lett. 18:523–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Young Park J, Wook Yun J, Whan Choi Y, Ung
Bae J, Won Seo K, Jin Lee S, Youn Park S, Whan Hong K and Kim CD:
Antihypertensive effect of gomisin A from Schisandra chinensis on
angiotensin II-induced hypertension via preservation of nitric
oxide bioavailability. Hypertens Res. 35:928–934. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Jang MK, Yun YR, Kim JH, Park MH and Jung
MH: Gomisin N inhibits adipogenesis and prevents high-fat
diet-induced obesity. Sci Rep. 7:403452017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yasukawa K, Ikeya Y, Mitsuhashi H, Iwasaki
M, Aburada M, Nakagawa S, Takeuchi M and Takido M: Gomisin A
inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in
two-stage carcinogenesis in mouse skin. Oncology. 49:68–71. 1992.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Oh SY, Kim YH, Bae DS, Um BH, Pan CH, Kim
CY, Lee HJ and Lee JK: Anti-inflammatory effects of gomisin N,
gomisin J, and schisandrin C isolated from the fruit of Schisandra
chinensis. Biosci Biotechnol Biochem. 74:285–291. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Fujihashi T, Hara H, Sakata T, Mori K,
Higuchi H, Tanaka A, Kaji H and Kaji A: Anti-human immunodeficiency
virus (HIV) activities of halogenated gomisin J derivatives, new
nonnucleoside inhibitors of HIV type 1 reverse transcriptase.
Antimicrob Agents Chemother. 39:2000–2007. 1995. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kim M, Lim SJ, Lee HJ, Kim SY and Nho CW:
Gomisin J inhibits oleic acid-induced hepatic lipogenesis by
activation of the AMPK-dependent pathway and inhibition of the
hepatokine fetuin-A in HepG2 cells. J Agric Food Chem.
63:9729–9739. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Ye BH, Lee SJ, Choi YW, Park SY and Kim
CD: Preventive effect of gomisin J from Schisandra chinensis on
angiotensin II-induced hypertension via an increased nitric oxide
bioavailability. Hypertens Res. 38:169–177. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Park JY, Choi YW, Yun JW, Bae JU, Seo KW,
Lee SJ, Park SY and Kim CD: Gomisin J from Schisandra chinensis
induces vascular relaxation via activation of endothelial nitric
oxide synthase. Vascul Pharmacol. 57:124–130. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Smejkal K, Slapetová T, Krmenčík P, Babula
P, Dall'Acqua S, Innocenti G, Vančo J, Casarin E, Carrara M,
Kalvarová K, et al: Evaluation of cytotoxic activity of Schisandra
chinensis lignans. Planta Med. 76:1672–1677. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Christofferson DE and Yuan J: Cyclophilin
A release as a biomarker of necrotic cell death. Cell Death Differ.
17:1942–1943. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discov Today. 16:715–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Feng H, Yang Z, Bai X, Yang M, Fang Y,
Zhang X, Guo Q and Ning H: Therapeutic potential of a dual mTORC1/2
inhibitor for the prevention of posterior capsule opacification: An
in vitro study. Int J Mol Med. 41:2099–2107. 2018.PubMed/NCBI
|
32
|
Donia M, Mangano K, Amoroso A, Mazzarino
MC, Imbesi R, Castrogiovanni P, Coco M, Meroni P and Nicoletti F:
Treatment with rapamycin ameliorates clinical and histological
signs of protracted relapsing experimental allergic
encephalomyelitis in Dark Agouti rats and induces expansion of
peripheral CD4+CD25+Foxp3+
regulatory T cells. J Autoimmun. 33:135–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Evangelisti C, Evangelisti C, Chiarini F,
Lonetti A, Buontempo F, Bressanin D, Cappellini A, Orsini E,
McCubrey JA and Martelli AM: Therapeutic potential of targeting
mTOR in T-cell acute lymphoblastic leukemia (Review). Int J Oncol.
45:909–918. 2014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Maharjan S, Park BK, Lee SI, Lim Y, Lee K,
Kwon HJ and Gomisin G: Gomisin G inhibits the growth of
triple-negative breast cancer cells by suppressing AKT
phosphorylation and decreasing cyclin D1. Biomol Ther (Seoul).
26:322–327. 2018. View Article : Google Scholar : PubMed/NCBI
|